Carbohydrate Antigen-125 and N-Terminal Pro-Brain Natriuretic Peptide Levels Compared in Heart-Failure Prognostication

Basit Öğe Kaydı
dc.contributor.authorOrdu, Serkan
dc.contributor.authorÖzhan, Hakan
dc.contributor.authorAlemdar, Recai
dc.contributor.authorAydın, Mesut
dc.contributor.authorÇağlar, Onur
dc.contributor.authorYüksel, Hatice
dc.contributor.authorKandiş, Hayati
dc.date.accessioned2020-04-30T22:40:31Z
dc.date.available2020-04-30T22:40:31Z
dc.date.issued2012
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionKandis, Hayati/0000-0001-9151-6050en_US
dc.descriptionWOS: 000300117800007en_US
dc.descriptionPubMed: 22412224en_US
dc.description.abstractCarbohydrate antigen-125 (CA-125) is emerging as a prognostic biomarker of risk in heart failure. In a prospective study, we compared the prognostic values of CA-125 and amino-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with stable heart failure. We enrolled 102 consecutive chronic, stable, systolic-heart-failure patients (68 men and 34 women; median age, 71 yr) from November 2008 through February 2010. We measured baseline NT-proBNP and CA-125 levels and compared their prognostic values. The primary endpoint was all-cause death and other major adverse events, defined as hospitalization for decompensated heart failure or acute coronary syndrome. During a mean follow-up period of 14 +/- 2 months, 12 patients died and 35 others sustained major adverse events. We found that CA-125 level significantly correlated with New York Heart Association functional class, pulmonary artery pressure, microalbuminuria, creatine kinase-MB fraction, and hemoglobin, albumin, and NT-proBNP levels. Upon receiver operating characteristic curve analysis, CA-125 and NT-proBNP had similar accuracy in predicting major adverse events and death: for major adverse events, area under the curve (AUG) was 0.699 for CA-125 (P=0.002) and 0.696 for NT-proBNP (P=0.002); for death, AUC was 0.784 for CA-125 (P=0.003) and 0.824 for NT-proBNP (P=0.001). Multivariate Cox regression analysis showed that CA-125 levels greater than 32 U/mL and NT-proBNP levels greater than 5,300 pg/mL had independent prognostic value for major adverse events and death. We conclude that baseline CA-125 and NT-proBNP levels are comparably reliable as heart-failure markers, and that CA-125 can be used for prognosis prediction in heart failure. (Tex Heart Inst J 2012;39(1):30-5)en_US
dc.identifier.endpage35en_US
dc.identifier.issn1526-6702
dc.identifier.issue1en_US
dc.identifier.startpage30en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12684/3001
dc.identifier.volume39en_US
dc.identifier.wosWOS:000300117800007en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTexas Heart Insten_US
dc.relation.ispartofTexas Heart Institute Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBiological markers/blooden_US
dc.subjectCA-125 antigen/blooden_US
dc.subjectdiagnostic tests, routine/utilizationen_US
dc.subjecthealth status indicatorsen_US
dc.subjectheart failure/physiopathologyen_US
dc.subjectnatriuretic peptide, brain/blooden_US
dc.subjectpredictive value of testsen_US
dc.subjectsensitivity and specificityen_US
dc.titleCarbohydrate Antigen-125 and N-Terminal Pro-Brain Natriuretic Peptide Levels Compared in Heart-Failure Prognosticationen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu